Investor Relations


Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.

Events & Presentations


Tuesday September 29, 2020 at 9:00 AM EDT
Incyte & MorphoSys Tafasitamab Expert Event

FRONT >> Events > View All


Tuesday August 4, 2020 at 8:00 AM EDT
Q2 2020 Incyte Corporation Earnings Conference Call

FRONT >> Events > View All

Investor Contacts

Michael Booth D.Phil
Division VP, Investor Relations & Corporate Responsibility
Phone: 302.498.5914

Lauren Ayala, MBA
Senior Director, Investor Relations & Corporate Responsibility
Phone: 302.498.6141

Christine Chiou
Senior Director, Investor Relations
Phone: 302.274.4773

Data Provided by Refinitiv. Minimum 15 minutes delayed.

04. Sidebar Quicklinks